Blood Coagulation Factors (Coagulation Factor)

Subscribe to Selected New Research on Blood Coagulation Factors

1580 relevant articles (42 outcomes, 128 trials/studies) found for this Bio-Agent

Description: Endogenous substances, usually proteins, that are involved in the blood coagulation process.

Also Known As:

Coagulation Factor; Coagulation Factors; Blood Coagulation Factor; Coagulation Factor, Blood; Coagulation Factors, Blood; Factor, Coagulation; Factors, Coagulation; Factor, Blood Coagulation; Factors, Blood Coagulation

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Proteins: 58433

Blood Proteins: 3862

Blood Coagulation Factors: 1580

Fibrinogen: 8128

Thrombin: 5307

Factor VIII: 4384

Plasminogen Activators: 4351

von Willebrand Factor: 3773

Factor IX: 2843

Prothrombin: 2833

Plasminogen Activator Inhibitor 1: 2428

beta-Thromboglobulin: 546

Platelet Factor 4: 538

Factor XII: 376

Kininogens: 352

Factor X: 321

Fibrinopeptide A: 318

prothrombin complex concentrates: 275

Factor XI: 267

Plasminogen Activator Inhibitor 2: 201

Feiba: 80

Platelet Factor 3: 67

leukocyte procoagulant activity: 47

macrophage procoagulant activity: 34

Fibrinopeptide B: 25

activated protein C receptor: 20

antiprothrombinase: 19

horseshoe crab coagulation factor G

human RPL29 protein

low affinity platelet factor 4

Nour-Eldin fraction

platelet factor 1

platelet procoagulant factor

Biological Factors: 931

Blood Coagulation Factors: 1580

Calcium: 37919

Fibrinogen: 8128

Thrombin: 5307

Tissue Plasminogen Activator: 4613

Factor VIII: 4384

von Willebrand Factor: 3773

Factor IX: 2843

Prothrombin: 2833

Platelet Activating Factor: 2458

Plasminogen Activator Inhibitor 1: 2428

beta-Thromboglobulin: 546

Platelet Factor 4: 538

Factor XII: 376

Kininogens: 352

Factor X: 321

Fibrinopeptide A: 318

prothrombin complex concentrates: 275

Factor XI: 267

Plasminogen Activator Inhibitor 2: 201

Feiba: 80

Platelet Factor 3: 67

leukocyte procoagulant activity: 47

macrophage procoagulant activity: 34

Fibrinopeptide B: 25

activated protein C receptor: 20

antiprothrombinase: 19

horseshoe crab coagulation factor G

human RPL29 protein

low affinity platelet factor 4

Nour-Eldin fraction

platelet factor 1

platelet procoagulant factor

Experts

1.	Li, Qin: 3 articles (08/2006 - 12/2004)
2.	Ma, Hong: 3 articles (08/2006 - 01/2005)
3.	Folsom, Aaron R: 2 articles (06/2008 - 12/2002)
4.	Aleksic, Nena: 2 articles (06/2008 - 12/2002)
5.	Rosendaal, F R: 2 articles (05/2008 - 10/2003)
6.	Rosendaal, Frits R: 2 articles (12/2006 - 03/2003)
7.	Jia, Ji-dong: 2 articles (08/2006 - 03/2005)
8.	Cong, Yu-long: 2 articles (08/2006 - 03/2005)
9.	Wang, Bao-en: 2 articles (08/2006 - 03/2005)
10.	Björkman, S: 2 articles (11/2004 - 01/2001)

Related Diseases

1.	Hemorrhage 01/01/1998 - "Coagulation factor replacement, appropriate care of the bleeding site and early physical therapy helps to prevent complications and yields the best results. " 10/01/1997 - "The marked decrease in hemorrhage seen in nactin-treated animals may reflect an interaction of Mac-1 with blood coagulation factors. " 01/01/2009 - "Fifteen children with bleeding disorders requiring prophylactic home treatment with coagulation factors were recruited to the study. " 01/01/1992 - "Rare inherited bleeding disorders secondary to coagulation factors in Jordan: a nine-year study." 01/01/1987 - "In order to study the mechanism underlying UK-induced hemorrhage, we observed the influences of UK and DF on blood coagulation factors in another 12 dogs. " Order ALL the reference details at left...
2.	Hemophilia A (Haemophilia) 01/01/2006 - "Plasma-derived concentrates of coagulation factors VIII and IX allow for effective treatment of haemophilia A and B. " 12/28/2002 - "It has been shown that this treatment is effective in patients with haemophilia and an inhibiting antibody against a coagulation factor. " 06/01/2000 - "The availability of new safe coagulation factors has improved the prognosis of haemophilia." 04/01/2004 - "Coagulation factors with improved properties for hemophilia gene therapy." 01/01/1982 - "Therapy with concentrated coagulation factors has greatly improved the management of hemophilia, but the consequence of repeated infusion of these blood products are unknown. " Order ALL the reference details at left...
3.	Thrombosis (Thrombus) 03/01/1999 - "Coagulation factor levels predict arterial thrombosis in epidemiological studies, but studies of older persons are needed. " 05/01/1989 - "Thrombosis of vessels at all levels was a prominent feature, suggesting that study of coagulation factors may be important. " 05/01/2009 - "Elevated levels of several coagulation factors have been found to be associated with an increased risk of thrombosis. " 08/01/2008 - "Conclusively, reversibility and synchrony of platelet integrin activation are newly identified mechanisms to restrict thrombus growth and to allow optimal coagulation factor binding. " 02/01/2008 - "After cleavage by the corresponding coagulation factor that occurs on the activation of the coagulation system and in the presence of the thrombus, its activity is released. " Order ALL the reference details at left...
4.	Infection 01/01/2000 - "The adoption of these measures has dramatically reduced the risk of transmission of bloodborne infections by plasma-derived coagulation factor concentrates. " 01/01/1991 - "This study confirms that replacement therapy with coagulation factors is accompanied by an increased risk for acquiring parvovirus B19 infection. " 04/01/2009 - "We conclude that the use of coagulation factors by adenoviruses may be of importance not only for the liver tropism seen when administering adenovirus vectors to the circulation but also during primary infections by wild-type viruses of their natural target cell types." 04/01/2009 - "By using a set of binding and infection experiments, we also found that Ad5 and Ad31 require coagulation factors IX (FIX) or X (FX) or just FIX, respectively, for efficient binding and infection. " 04/01/2009 - "Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells." Order ALL the reference details at left...
5.	Acquired Immunodeficiency Syndrome (AIDS) 06/01/1994 - "Those students who thought that "the number of HIV-infected persons will rapidly increase" tended to respond that "they are worried about getting AIDS in the future"; "they will not change their attitudes to their HIV-infected friends"; and "the persons who got AIDS through coagulation factor products should be supported." The results also show that a seminar about HIV/AIDS that provides information in a short period of time is effective in reducing prejudice and improving attitudes toward HIV-infected persons." 06/01/2000 - "From the beginning of the follow-up of AIDS patients in 1987, only 7 (2%) of hemophiliacs have been HIV-infected, all before 1990 and due to non-inactivated coagulation factor concentrates. " 07/01/1999 - "Our group conducted a national survey of patients who had died of acquired immunodeficiency syndrome (AIDS) after being infected with human immunodeficiency virus type 1 (HIV-1) by contaminated blood coagulation factor products. " 01/01/1984 - "Exposure to the AIDS-associated retrovirus (ARV) has been observed in 54 hemophiliacs in Southern Spain who have received commercial coagulation factors manufactured in the United States. " 09/01/1990 - "Coagulation factor concentrates, as traditionally prepared, are known to have transmitted the viral agents of hepatitis and AIDS with high frequency. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Vitamin K
2.	Fibrinogen (Factor I)
3.	Heparin (Liquaemin)
4.	Factor VIII (Coagulation Factor VIII)
5.	Vitamin K 1 (Phylloquinone)
6.	Thrombin
7.	Warfarin (Coumadin)
8.	Glucose (Dextrose)
9.	Beriplex P-N
10.	Dacarbazine (DIC)

Related Therapies and Procedures

1.	Platelet Transfusion (Blood Platelet Transfusions)
2.	Erythrocyte Transfusion
3.	Blood Transfusion (Blood Transfusions)
4.	Donor Selection
5.	Injections

Best Treatments:
Research Summary Report
on Hemorrhage

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3107 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>